%PDF-1.4
%
40 0 obj
<>
endobj
37 0 obj
<>
endobj
96 0 obj
<>stream
Acrobat Distiller 4.05 for Macintosh
2004-11-29T10:41:41Z
2012-02-24T14:09:59-08:00
QuarkXPressª: AdobePS 8.6 (219)
2012-02-24T14:09:59-08:00
application/pdf
Heather
200664 aug
uuid:60dabfdf-1dd2-11b2-0a00-c809271c8e00
uuid:60dabfe3-1dd2-11b2-0a00-14f600000000
endstream
endobj
26 0 obj
<>
endobj
27 0 obj
<>
endobj
97 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
41 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
4 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
7 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
10 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
126 0 obj
<>stream
1 g
/GS0 gs
q 1 0 0 1 0 792 cm
0 0 m
0 0 l
f
Q
q
-1 793 614 -794 re
W n
q
0 792.06 612 -792 re
W n
BT
/CS0 cs 0 0 0 1 scn
/GS1 gs
/TT0 1 Tf
0.0249 Tw 8 0 0 8 74.4 714.5293 Tm
[(and Hiscock\222)54.9 (s forced choice memory test. J Clin Exp Neuropsychol)]TJ
0 Tw 0 -1.25 TD
(1994;16:472-81.)Tj
0.02499 Tw -2.175 -1.25 Td
[(17.)-875 (Pankratz L, Binder LM. Malingering on intellectual and)]TJ
2.175 -1.25 Td
[(neuropsychological measures. In: Rogers R, editor)54.9 (. Clinical)]TJ
T*
[(assessment of malingering and deception. New )36.8 (Y)100.1 (ork: Guilford;)]TJ
0 Tw T*
(1997:223-6.)Tj
0.0249 Tw -2.175 -1.25 Td
[(18.)-875 (Green P)110.8 (,)0.1 ( Iverson GL, )54.8 (Allen L. Detecting malingering in head injury)]TJ
2.175 -1.25 Td
[(litigation with the )17.7 (W)79.8 (ord Memory )17.7 (T)69.8 (est. Brain Inj 1999;13:813-9.)]TJ
-2.175 -1.25 Td
[(19.)-875 (Hart RP)110.8 (, Martelli MF)79.8 (, Zasler ND. Chronic pain and)]TJ
2.175 -1.25 Td
(neuropsychological functioning. Neuropsychol Rev)Tj
0 Tw 0.275 -1.25 Td
(2000;10:131-49.)Tj
0.0249 Tw -2.45 -1.25 Td
[(20.)-875 (Green P)110.8 (,)0.1 ( Iverson GL. )17.7 (V)111.1 (alidation of the Computerized )54.8 (Assessment)]TJ
2.175 -1.25 Td
(of Response Bias in litigating patients with head injuries. Clin)Tj
-0.00011 Tc T*
(Neuropsychol, in press.)Tj
0 Tc -2.175 -1.25 Td
[(21.)-875 (Allen LM, Green P)110.8 (.)0.1 ( Severe )17.7 (TBI sample performance on CARB and)]TJ
2.175 -1.25 Td
[(the )17.7 (WMT)-257.2 (\(Supplement to the CARB \22297 and )17.7 (W)79.8 (ord Memory )17.7 (T)69.8 (est)]TJ
-0.00011 Tc T*
[(manuals and CARB/WMT)-257.3 (scoring software\). Durham, NC:)]TJ
0 Tc T*
(CogniSyst, Inc.; 1999.)Tj
-2.175 -1.25 Td
[(22.)-875 (Green P)110.8 (, )54.8 (Allen LM. Performance of neurological patients on the)]TJ
2.175 -1.25 Td
[(W)79.8 (ord Memory )17.7 (T)69.8 (est \(WMT\) and Computerized )54.8 (Assessment of)]TJ
T*
[(Response Bias \(CARB\) \(supplement to the CARB \22297 and )17.8 (W)79.8 (ord)]TJ
-0.00011 Tc T*
[(Memory )17.7 (T)69.7 (est manuals and CARB/WMT)-257.3 (scoring software\).)]TJ
0 Tc T*
(Durham, NC: CogniSyst, Inc.; 1999.)Tj
-0.00011 Tc -2.175 -1.25 Td
[(23.)-875.1 (Iverson GL, Green P)110.7 (, Gervais R. Using the )17.7 (W)79.7 (ord Memory )17.7 (T)69.7 (est to)]TJ
0 Tc 2.175 -1.25 Td
(detect biased responding in head injury litigation. J Cogn Rehabil)Tj
0 Tw T*
(1999;17:4-8.)Tj
0.02499 Tw -2.175 -1.25 Td
[(24.)-875 (Conder R, )54.9 (Allen L, Cox D. Manual for the Computerized)]TJ
-0.00011 Tc 2.175 -1.25 Td
(Assessment of Response Bias. Durham, NC: CogniSyst, Inc; 1992.)Tj
0 Tc -2.175 -1.25 Td
[(25.)-875 (Allen LM, Conder RL, Green P)110.8 (, Cox DR. CARB \22297 manual for)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(the Computerized )54.8 (Assessment of Response Bias. Durham, NC:)]TJ
0 Tc T*
(CogniSyst, Inc.; 1997.)Tj
-0.00011 Tc 30.825 37.5 Td
[(26.)-875.1 (Green P)110.7 (,)-0.1 ( )54.8 (Allen LM, )54.8 (Astner K. )17.7 (The )17.7 (W)79.7 (ord Memory )17.7 (T)69.7 (est: )54.8 (A)-219.9 (user)-37 (\222)55.1 (s)]TJ
2.175 -1.25 Td
[(guide to the oral and computer)19.7 (-administered forms, US version 1.1.)]TJ
0 Tc T*
(Durham, NC: CogniSyst, Inc.; 1996.)Tj
-2.175 -1.25 Td
[(27.)-875 (Derogatis LR. Symptom Checklist-90-Revised. Minneapolis, MN:)]TJ
2.175 -1.25 Td
(National Computer Systems, Inc.; 1994.)Tj
-2.175 -1.25 Td
[(28.)-875 (Green P)110.8 (, )54.8 (Allen LM. Memory Complaints Inventory)64.9 (.)0.1 ( Durham, NC:)]TJ
2.175 -1.25 Td
(Cognisyst, Inc.; 1997.)Tj
-2.175 -1.25 Td
[(29.)-875 (W)79.8 (echsler D. )17.7 (W)79.8 (echsler )54.8 (Adult Intelligence Scale-Revised. Cleveland:)]TJ
2.175 -1.25 Td
(Psychological Corporation; 1981.)Tj
-2.175 -1.25 Td
[(30.)-875 (Burckhardt CS, Clark SR, Bennett RM. )17.8 (The Fibromyalgia Impact)]TJ
2.175 -1.25 Td
(Questionnaire: development and validation. J Rheumatol)Tj
0 Tw T*
(1991;18:728-33.)Tj
0.02499 Tw -2.175 -1.25 Td
[(31. )-600 (Iverson GL, Binder LM. Detecting exaggeration and malingering in)]TJ
-0.00011 Tc 2.175 -1.25 Td
[(neuropsychological assessment. J Head )17.7 (T)34.8 (rauma Rehabil)]TJ
0 Tc 0 Tw T*
(2000;15:829-58.)Tj
0.02499 Tw -2.175 -1.25 Td
[(32.)-875 (Schmand B, Lindeboom J, Schagen S, Heijt R, Koene )17.8 (T)74 (,)]TJ
2.175 -1.25 Td
[(Hambur)17.8 (ger HL. Cognitive complaints in patients after whiplash)]TJ
T*
[(injury: the impact of malingering. J Neurol Neurosur)17.8 (g Psychiatry)]TJ
0 Tw T*
(1998;64:339-43.)Tj
-0.00011 Tc 0.02499 Tw -2.175 -1.25 Td
[(33.)-875.1 (Rohling ML, Green P)110.7 (,)-0.1 ( )54.8 (Allen LM, Iverson GL. Depressive)]TJ
0 Tc 2.175 -1.25 Td
(symptoms and neurocognitive test scores in patients passing)Tj
-0.00011 Tc T*
[(symptom validity tests. )54.8 (Arch Clin Neuropsych, in press.)]TJ
-2.175 -1.25 Td
[(34.)-875.1 (Beck )54.8 (A)111 (T)73.9 (, Steer RA. Beck Depression Inventory)64.8 (. San )54.8 (Antonio, )17.7 (TX:)]TJ
0 Tc 2.175 -1.25 Td
(Psychological Corporation; 1993.)Tj
-2.175 -1.25 Td
[(35.)-875 (Carroll KM, Rounsaville BJ, Nich C. Blind man\222)54.9 (s bluf)17.8 (f:)]TJ
2.175 -1.25 Td
[(ef)17.8 (fectiveness and significance of psychotherapy and)]TJ
T*
(pharmacotherapy blinding procedures in a clinical trial. )Tj
T*
(J Consult Clin Psychol 1994;62:276-80.)Tj
-2.175 -1.25 Td
[(36.)-875 (Frederick RI, Crosby RD. Development and validation of the)]TJ
2.175 -1.25 Td
[(V)111.1 (alidity Indicator Profile. Law Hum Behav 2000;24:59-82.)]TJ
ET
/CS0 CS 0 0 0 1 SCN
q 1 0 0 1 54 54 cm
0 0 m
504 0 l
S
Q
BT
/TT1 1 Tf
8 0 0 8 54.5 35.9844 Tm
(Gervais, et al: Effort testing in FM)Tj
0 Tw 60.9375 -0.0313 Td
(1899)Tj
ET
0 0 0 0 scn
/GS0 gs
103.47 59.75 407.5 -10.83 re
f*
0.5 w
103.47 59.75 407.5 -10.83 re
S
Q
Q
q
0 0 612 792 re
W n
BT
0 g
/GS2 gs
/T1_0 8 Tf
120.092 51 Td
(Personal non-commercial use only. The Journal of Rheumatology Copyright\
\251 2001. All rights reserved.)Tj
ET
Q
endstream
endobj
79 0 obj
<>
endobj
48 0 obj
<>
endobj
43 0 obj
<>
endobj
45 0 obj
<>
endobj
73 0 obj
<>stream
HV pUBBzI$cIHr$8A\D0 YR*"!e5)ŢZ9\ʢY
Lד U[/MC Z((\voZ_1P֝ұU꺓@WZ3_?հ0o m`EgG3^ZXqz[@l!PPY(~hͧOJ
i> s+/u@xivi >LG>*:2_Iˁw7Kږ|A<gϛoݤ%
znyW?dB:'kUAVJ
Fh/mPЄV}A1. zBbPY؎J]X8PCt ؉C8Y"I;8.>Vk
#=먳F!Y-QE\o]|ed^NcLi]G,ш!(N[Dk.:/<"z"ۏ3b4ZKWO'\0:|fdb5[i+!3w*fq8q E$BL#Sҫ.5FfF
+$ DS0HE_/T+K0N8Y~D>9XW$5#{^agΣwpOh)"D✌qҐy%SVO4o.峊9'3qsawXʱ
gs}'q_ubhM='(+R8҄UʮF,bx]n8JH*SyB+YTRk|H-P'
Z6][j;
= VaXMVCxH&:c9
yҦ,f?@1afw]?g}:':ղAO8+jcҗ3iwVfS=LOnΥw뚚ۥb:Fwj.2TE
dy~Lj1r _NшmL6вWVKCK`w5th7}\7u%^a72_7_#j*^>5iZ;w;
iloG6X\ɶIFL4:%(3.W;yF c1=t晎<_J}gદ3ʌ-:eFꥄG샕wU[*M6"PҬm.ܨtƔˊ}X
׆ޚD%i7*3yRĄ]IIf?j^=8gg@~.NXDƝ՜d%kvsA%Om;p &l ƳKuL%W`iE32hTK1O`KmGZOvL3#=g&BsgFun&T(dYwn&JȘ}]dgok>ٚ~q7OX3"_ǘʁ:IB[C
I%V?RT/}Q=
)bqE8Ց#!+"(o*K9/
۞TJ'u%IR*ii=R6}IЎC)H